D. Coëtmeur

1.5k total citations
37 papers, 549 citations indexed

About

D. Coëtmeur is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, D. Coëtmeur has authored 37 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in D. Coëtmeur's work include Lung Cancer Research Studies (15 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Diagnosis and Treatment (14 papers). D. Coëtmeur is often cited by papers focused on Lung Cancer Research Studies (15 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Diagnosis and Treatment (14 papers). D. Coëtmeur collaborates with scholars based in France, French Polynesia and Colombia. D. Coëtmeur's co-authors include M Grivaux, T. Collon, F Blanchon, G. Chatté, B. Crestani, Jean-François Cordier, Romain Lazor, D. Debieuvre, Mahmoud Zureik and Jean-Luc Breton and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

D. Coëtmeur

35 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Coëtmeur France 13 433 253 121 85 74 37 549
Federico Bianciardi Italy 11 324 0.7× 203 0.8× 53 0.4× 71 0.8× 100 1.4× 17 609
Ariane Steindl Austria 13 150 0.3× 171 0.7× 45 0.4× 96 1.1× 56 0.8× 39 418
Pier Carlo Gentile Italy 4 201 0.5× 185 0.7× 44 0.4× 96 1.1× 40 0.5× 6 515
Shehla Sheikh Canada 7 314 0.7× 290 1.1× 22 0.2× 78 0.9× 13 0.2× 15 456
Bünyamin Kaplan Türkiye 10 89 0.2× 124 0.5× 32 0.3× 68 0.8× 11 0.1× 21 281
L. Gérinière France 11 228 0.5× 221 0.9× 60 0.5× 82 1.0× 19 0.3× 37 397
Joshua Siglin United States 12 172 0.4× 85 0.3× 58 0.5× 48 0.6× 105 1.4× 19 400
Melissa M. Hudson United States 11 61 0.1× 94 0.4× 34 0.3× 24 0.3× 38 0.5× 20 429
Bong-Seog Kim South Korea 10 130 0.3× 121 0.5× 51 0.4× 60 0.7× 19 0.3× 15 296
T. Jorgensen United States 7 43 0.1× 146 0.6× 24 0.2× 57 0.7× 130 1.8× 9 387

Countries citing papers authored by D. Coëtmeur

Since Specialization
Citations

This map shows the geographic impact of D. Coëtmeur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Coëtmeur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Coëtmeur more than expected).

Fields of papers citing papers by D. Coëtmeur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Coëtmeur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Coëtmeur. The network helps show where D. Coëtmeur may publish in the future.

Co-authorship network of co-authors of D. Coëtmeur

This figure shows the co-authorship network connecting the top 25 collaborators of D. Coëtmeur. A scholar is included among the top collaborators of D. Coëtmeur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Coëtmeur. D. Coëtmeur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coëtmeur, D., Éric Parrat, G. Mangiapan, et al.. (2020). Activité physique et asthme sévère : résultats de l’étude FASE-CPHG. Revue des Maladies Respiratoires. 37(4). 320–327. 4 indexed citations
2.
Debieuvre, D., L. Moreau, Mathieu Coudert, et al.. (2019). Erlotinib en 2e ou 3e ligne pour les cancers bronchiques non à petites cellules sans mutation de l’EGFR : données en vie réelle. Revue des Maladies Respiratoires. 36(6). 649–663. 1 indexed citations
3.
Grivaux, M, François Goupil, Bernard Asselain, et al.. (2017). Stratégies thérapeutiques les 2 premières années après un diagnostic de cancer du poumon. ESCAP-2011-CPHG, étude en situation réelle réalisée dans les hôpitaux généraux français. Revue des Maladies Respiratoires. 34(9). 991–999. 7 indexed citations
4.
5.
6.
Locher, Chrystèle, D. Debieuvre, D. Coëtmeur, et al.. (2013). Major changes in lung cancer over the last ten years in France: The KBP-CPHG studies. Lung Cancer. 81(1). 32–38. 74 indexed citations
7.
Coëtmeur, D., et al.. (2012). Étude KBP–2010–CPHG : recueil des nouveaux cas de cancer broncho-pulmonaire primitif diagnostiqués dans les services de pneumologie des CHG en 2010. Revue des Maladies Respiratoires. 29(9). 1183–1184. 1 indexed citations
8.
9.
Blanchon, F, M Grivaux, Mahmoud Zureik, et al.. (2006). CohorteKbp-2000-Cphg : évaluation des facteurs pronostiques de la survie du cancer bronchique primitif à 2 et 5 ans. Revue des Maladies Respiratoires. 23(2). 165–171. 12 indexed citations
10.
Piquet, J., F Blanchon, M Grivaux, et al.. (2004). Le cancer bronchique primitif du sujet âgé en France. Revue des Maladies Respiratoires. 21(5). 70–78. 9 indexed citations
11.
Quoix, Élisabeth, Jean-Luc Breton, Casey L. Daniel, et al.. (2001). Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study. Annals of Oncology. 12(7). 957–962. 38 indexed citations
12.
Lazor, Romain, et al.. (2001). Tracheobronchopathia Osteochondroplastica. Medicine. 80(6). 378–390. 91 indexed citations
13.
Quoix, Élisabeth, Jean-Luc Breton, Casey L. Daniel, et al.. (2000). Tolerability of a combination of carboplatin and etoposide phosphate in elderly patients with small cell lung cancer. A multicentric phase II clinical trial. Lung Cancer. 29(1). 41–41. 3 indexed citations
14.
Urban, T., Claude Chastang, L Jeannin, et al.. (1999). Standard combination versus alternating chemotherapy in small cell lung cancer. Lung Cancer. 25(2). 105–113. 15 indexed citations
15.
Coëtmeur, D., et al.. (1998). [Acute eosinophilic pneumonia. Possible role of chloroquine].. PubMed. 15(5). 657–60. 9 indexed citations
16.
Coëtmeur, D., et al.. (1997). Tracheobronchopathia osteochondroplastica presenting at the time of a difficult intubation. Respiratory Medicine. 91(8). 496–498. 36 indexed citations
17.
Lemaître, Nadine, Wladimir Sougakoff, D. Coëtmeur, et al.. (1996). Nosocomial transmission of tuberculosis among mentally-handicapped patients in a long-term care facility. Tubercle and Lung Disease. 77(6). 531–536. 14 indexed citations
18.
Lebeau, B, C Chastang, Luc Thiberville, et al.. (1995). Chimiothérapie des cancers bronchiques à petites cellules. Importance pronostique d'une réponse complète (1,280 patients). Groupe Petites Cellules.. La Presse Médicale. 24(4). 2 indexed citations
19.
Depierre, A, B. Milleron, D Moro, et al.. (1995). 1053 Phase III study of neo-adjuvant chemotherapy in resectable non-small cell lung cancer (NSCLC). European Journal of Cancer. 31. S220–S220. 1 indexed citations
20.
Dautzenberg, Bertrand, Jacques Bénichou, B Lebeau, et al.. (1990). Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma results from a randomized phase II trial. Cancer. 65(11). 2435–2441. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Federico Bianciardi Breakdown of academic impact, for papers by Ariane Steindl Breakdown of academic impact, for papers by Pier Carlo Gentile Breakdown of academic impact, for papers by Shehla Sheikh Breakdown of academic impact, for papers by Bünyamin Kaplan Breakdown of academic impact, for papers by L. Gérinière Breakdown of academic impact, for papers by Joshua Siglin Breakdown of academic impact, for papers by Melissa M. Hudson Breakdown of academic impact, for papers by Bong-Seog Kim Breakdown of academic impact, for papers by T. Jorgensen
Rankless by CCL
2026